Detailed information for compound 2002756

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 332.444 | Formula: C15H16N4OS2
  • H donors: 1 H acceptors: 2 LogP: 2.01 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: S=c1[nH]c2sc3c(c2c(=O)n1CCCn1cncc1)CCC3
  • InChi: 1S/C15H16N4OS2/c20-14-12-10-3-1-4-11(10)22-13(12)17-15(21)19(14)7-2-6-18-8-5-16-9-18/h5,8-9H,1-4,6-7H2,(H,17,21)
  • InChiKey: MSBHQHBFHGRWJF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glutaminyl-peptide cyclotransferase Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Onchocerca volvulus Glutaminyl cyclase homolog Get druggable targets OG5_129821 All targets in OG5_129821
Echinococcus granulosus glutaminyl peptide cyclotransferase Get druggable targets OG5_129821 All targets in OG5_129821
Schistosoma japonicum ko:K00683 glutaminyl-peptide cyclotransferase [EC2.3.2.5], putative Get druggable targets OG5_129821 All targets in OG5_129821
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_129821 All targets in OG5_129821
Brugia malayi Peptidase family M28 containing protein Get druggable targets OG5_129821 All targets in OG5_129821
Schistosoma mansoni glutaminyl cyclase (M28 family) Get druggable targets OG5_129821 All targets in OG5_129821
Echinococcus multilocularis glutaminyl peptide cyclotransferase Get druggable targets OG5_129821 All targets in OG5_129821

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus endoplasmic reticulum metallopeptidase 1 glutaminyl-peptide cyclotransferase 361 aa 292 aa 21.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Schistosoma mansoni hypothetical protein 0.0189 1 1
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trypanosoma brucei metacaspase 0.003 0.0473 0.0795
Loa Loa (eye worm) hypothetical protein 0.003 0.0473 0.069
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Treponema pallidum diphosphate--fructose-6-phosphate 1-phosphotransferase 0.0121 0.595 1
Mycobacterium ulcerans 6-phosphofructokinase 0.0121 0.595 1
Schistosoma mansoni caspase-7 (C14 family) 0.003 0.0473 0.0473
Trichomonas vaginalis 6-phosphofructokinase, putative 0.0033 0.0661 0.1111
Brugia malayi 6-phosphofructokinase 0.0121 0.595 0.8684
Echinococcus multilocularis caspase 8 0.003 0.0473 0.0473
Brugia malayi 6-phosphofructokinase 0.0121 0.595 0.8684
Echinococcus multilocularis caspase 3, apoptosis cysteine peptidase 0.003 0.0473 0.0473
Leishmania major ATP-dependent phosphofructokinase 0.0121 0.595 1
Plasmodium vivax 6-phosphofructokinase, putative 0.0033 0.0661 1
Echinococcus granulosus 6 phosphofructokinase 0.0121 0.595 0.595
Toxoplasma gondii phosphofructokinase PFKII 0.0033 0.0661 1
Trypanosoma brucei Metacaspase-4 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0121 0.595 1
Echinococcus multilocularis caspase 0.003 0.0473 0.0473
Trypanosoma cruzi metacaspase, putative 0.003 0.0473 0.0795
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Chlamydia trachomatis fructose-6-phosphate phosphotransferase 0.0033 0.0661 0.5
Brugia malayi Cell death protein 3 precursor 0.003 0.0473 0.069
Loa Loa (eye worm) hypothetical protein 0.0136 0.6852 1
Echinococcus granulosus caspase 0.003 0.0473 0.0473
Schistosoma mansoni caspase-3 (C14 family) 0.003 0.0473 0.0473
Loa Loa (eye worm) phosphofructokinase 0.0121 0.595 0.8684
Toxoplasma gondii ICE family protease (caspase) p20 domain-containing protein 0.003 0.0473 0.7152
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Loa Loa (eye worm) hypothetical protein 0.003 0.0473 0.069
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Brugia malayi phosphofructokinase 0.0121 0.595 0.8684
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trypanosoma brucei metacaspase MCA2 0.003 0.0473 0.0795
Trypanosoma brucei ATP-dependent 6-phosphofructokinase, glycosomal 0.0121 0.595 1
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0121 0.595 1
Trypanosoma cruzi metacaspase, putative 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Echinococcus granulosus caspase 8 0.003 0.0473 0.0473
Toxoplasma gondii ICE family protease (caspase) p20 domain-containing protein 0.003 0.0473 0.7152
Trypanosoma cruzi metacaspase, putative 0.003 0.0473 0.0795
Mycobacterium leprae PROBABLE 6-PHOSPHOFRUCTOKINASE PFKA (PHOSPHOHEXOKINASE) (PHOSPHOFRUCTOKINASE) 0.0121 0.595 0.5
Echinococcus granulosus caspase 3 apoptosis cysteine peptidase 0.003 0.0473 0.0473
Trypanosoma brucei metacaspase MCA3 0.003 0.0473 0.0795
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0121 0.595 1
Trypanosoma cruzi ATP-dependent 6-phosphofructokinase, glycosomal 0.0121 0.595 1
Giardia lamblia Pyrophosphate-fructose 6-phosphate 1-phosphotransferase alpha subunit 0.0033 0.0661 0.5
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Schistosoma mansoni hypothetical protein 0.0189 1 1
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Plasmodium falciparum ATP-dependent 6-phosphofructokinase 0.0033 0.0661 1
Toxoplasma gondii 6-phosphofructokinase 0.0033 0.0661 1
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Toxoplasma gondii ICE family protease (caspase) p20 domain-containing protein 0.003 0.0473 0.7152
Schistosoma mansoni glutaminyl cyclase (M28 family) 0.0136 0.6852 0.6852
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Chlamydia trachomatis fructose-6-phosphate phosphotransferase 0.0033 0.0661 0.5
Echinococcus multilocularis caspase 2 0.003 0.0473 0.0473
Schistosoma mansoni 6-phosphofructokinase 0.0121 0.595 0.595
Onchocerca volvulus Glutaminyl cyclase homolog 0.0136 0.6852 1
Plasmodium falciparum ATP-dependent 6-phosphofructokinase 0.0033 0.0661 1
Entamoeba histolytica phosphofructokinase, putative 0.0121 0.595 1
Mycobacterium tuberculosis Probable 6-phosphofructokinase PfkA (phosphohexokinase) (phosphofructokinase) 0.0121 0.595 1
Echinococcus multilocularis geminin 0.0189 1 1
Echinococcus multilocularis glutaminyl peptide cyclotransferase 0.0136 0.6852 0.6852
Trichomonas vaginalis Clan CD, family C14, metacaspase-like cysteine peptidase 0.003 0.0473 0.0795
Trypanosoma brucei metacaspase 5, putative 0.003 0.0473 0.0795
Echinococcus granulosus glutaminyl peptide cyclotransferase 0.0136 0.6852 0.6852
Onchocerca volvulus Cell death protein 3 homolog 0.003 0.0473 0.069
Echinococcus granulosus caspase 2 0.003 0.0473 0.0473
Loa Loa (eye worm) 6-phosphofructokinase 0.0121 0.595 0.8684
Plasmodium vivax 6-phosphofructokinase, putative 0.0033 0.0661 1
Leishmania major metacaspase, putative 0.003 0.0473 0.0795
Trypanosoma cruzi metacaspase 5, putative 0.003 0.0473 0.0795
Entamoeba histolytica phosphofructokinase, putative 0.0121 0.595 1
Trypanosoma cruzi metacaspase 5, putative 0.003 0.0473 0.0795
Brugia malayi Peptidase family M28 containing protein 0.0136 0.6852 1
Loa Loa (eye worm) 6-phosphofructokinase 0.0121 0.595 0.8684
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Trypanosoma cruzi metacaspase, putative 0.003 0.0473 0.0795
Echinococcus multilocularis 6 phosphofructokinase 0.0121 0.595 0.595
Trichomonas vaginalis phosphofructokinase, putative 0.0121 0.595 1
Schistosoma mansoni subfamily C14A unassigned peptidase (C14 family) 0.003 0.0473 0.0473
Entamoeba histolytica phosphofructokinase, putative 0.0121 0.595 1
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Schistosoma mansoni 6-phosphofructokinase 0.0121 0.595 0.595
Brugia malayi mucosa associated lymphoid tissue lymphoma translocation protein 1 0.003 0.0473 0.069
Trichomonas vaginalis conserved hypothetical protein 0.003 0.0473 0.0795
Trichomonas vaginalis phosphofructokinase, putative 0.0033 0.0661 0.1111
Schistosoma mansoni caspase-7 (C14 family) 0.003 0.0473 0.0473
Toxoplasma gondii phosphofructokinase domain-containing protein 0.0033 0.0661 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 5850 nM BindingDB_Patents: Inhibition Assay. Fluorometric Assays: All measurements were performed with a BioAssay Reader HTS-7000Plus for microplates (Perkin Elmer) at 30 C. QC activity was evaluated fluorometrically using H-Gln-beta NA. The samples consisted of 0.2 mM fluorogenic substrate, 0.25 U pyroglutamyl aminopeptidase (Unizyme, Horsholm, Denmark) in 0.2 M Tris/HCl, pH 8.0 containing 20 mM EDTA and an appropriately diluted aliquot of QC in a final volume of 250 ul. Excitation/emission wavelengths were 320/410 nm. The assay reactions were initiated by addition of glutaminyl cyclase. QC activity was determined from a standard curve of beta -naphthylamine under assay conditions. One unit is defined as the amount of QC catalyzing the formation of 1 umol pGlu-beta NA from H-Gln-beta NA per minute under the described conditions.In a second fluorometric assay, QC was activity determined using H-Gln-AMC as substrate. Reactions were carried out at 30 C. utilizing the NOVOStar reader for microplates (BMG labtechnology). ChEMBL. No reference
Ki (binding) = 615 nM BindingDB_Patents: Inhibition Assay. Fluorometric Assays: All measurements were performed with a BioAssay Reader HTS-7000Plus for microplates (Perkin Elmer) at 30 C. QC activity was evaluated fluorometrically using H-Gln-beta NA. The samples consisted of 0.2 mM fluorogenic substrate, 0.25 U pyroglutamyl aminopeptidase (Unizyme, Horsholm, Denmark) in 0.2 M Tris/HCl, pH 8.0 containing 20 mM EDTA and an appropriately diluted aliquot of QC in a final volume of 250 ul. Excitation/emission wavelengths were 320/410 nm. The assay reactions were initiated by addition of glutaminyl cyclase. QC activity was determined from a standard curve of beta -naphthylamine under assay conditions. One unit is defined as the amount of QC catalyzing the formation of 1 umol pGlu-beta NA from H-Gln-beta NA per minute under the described conditions.In a second fluorometric assay, QC was activity determined using H-Gln-AMC as substrate. Reactions were carried out at 30 C. utilizing the NOVOStar reader for microplates (BMG labtechnology). ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.